AC regimen: Difference between revisions

	WikiDoc Resources for AC regimen
Articles
Most recent articles on AC regimen Most cited articles on AC regimen Review articles on AC regimen Articles on AC regimen in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on AC regimen Images of AC regimen Photos of AC regimen Podcasts & MP3s on AC regimen Videos on AC regimen
Evidence Based Medicine
Cochrane Collaboration on AC regimen Bandolier on AC regimen TRIP on AC regimen
Clinical Trials
Ongoing Trials on AC regimen at Clinical Trials.gov Trial results on AC regimen Clinical Trials on AC regimen at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on AC regimen NICE Guidance on AC regimen NHS PRODIGY Guidance FDA on AC regimen CDC on AC regimen
Books
Books on AC regimen
News
AC regimen in the news Be alerted to news on AC regimen News trends on AC regimen
Commentary
Blogs on AC regimen
Definitions
Definitions of AC regimen
Patient Resources / Community
Patient resources on AC regimen Discussion groups on AC regimen Patient Handouts on AC regimen Directions to Hospitals Treating AC regimen Risk calculators and risk factors for AC regimen
Healthcare Provider Resources
Symptoms of AC regimen Causes & Risk Factors for AC regimen Diagnostic studies for AC regimen Treatment of AC regimen
Continuing Medical Education (CME)
CME Programs on AC regimen
International
AC regimen en Espanol AC regimen en Francais
Business
AC regimen in the Marketplace Patents on AC regimen
Experimental / Informatics
List of terms related to AC regimen

← Older edit Newer edit →

VisualWikitext

Revision as of 15:57, 27 February 2015

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Synonyms and keywords: AC; AC Regimen; Adriamycin-Cytoxan Regimen; CA Regimen.

Overview

AC regimen refers to a regimen consisting of cyclophosphamide and doxorubicin used in the adjuvant setting for the treatment of breast cancer; also used for the treatment of recurrent and metastatic breast cancer.^[1]^[2]

Regimen

A– Doxorubicin (Adriamycin)

C – Cyclophosphamide

Indications

Recurrent and metastatic breast cancer.^[3]

References

↑ "NCI Thesaurus".
↑ "R-CHOP - National Cancer Institute".
↑ Perez EA, Geeraerts L, Suman VJ, Adjei AA, Baron AT, Hatfield AK; et al. (2002). "A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer". Ann Oncol. 13 (8): 1225–35. PMID 12181246.

[1] "NCI Thesaurus".

[2] "R-CHOP - National Cancer Institute".

[pmid12181246-3] Perez EA, Geeraerts L, Suman VJ, Adjei AA, Baron AT, Hatfield AK; et al. (2002). "A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer". Ann Oncol. 13 (8): 1225–35. PMID 12181246.

[1]

[2]

[3]

@@ Line 15: / Line 15: @@
 ==Indications==
-* [[Breast cancer|Recurrent and metastatic breast cancer]].
+* [[Breast cancer|Recurrent and metastatic breast cancer]].<ref name="pmid12181246">{{cite journal| author=Perez EA, Geeraerts L, Suman VJ, Adjei AA, Baron AT, Hatfield AK et al.| title=A randomized phase II study of sequential docetaxel and doxorubicin/cyclophosphamide in patients with metastatic breast cancer. | journal=Ann Oncol | year= 2002 | volume= 13 | issue= 8 | pages= 1225-35 | pmid=12181246 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12181246  }} </ref>
 ==References==